Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Modesto, Santa Rosa, Solano/Vallejo, Palo Alto/Santa Cruz, Greater Sacramento Valley, San Mateo, East Bay, San Francisco
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Principal Investigator
Related Studies
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Using EHR from a large healthcare system in Northern CA, we will study the impact of smoking, comorbidities, race on COVID-19 infection and disease severity.
Investigator: Jiang Li, Ph.D., MPH